|
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
|
5R21CA184920-02
|
$131,805
|
$131,805
|
MARTINEZ, JESSE
|
UNIVERSITY OF ARIZONA
|
|
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
|
5R01CA180083-03
|
$521,783
|
$521,783
|
QIN, LIDONG
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
4D Robust Optimization in Intensity-Modulated Proton Therapy
|
5K25CA168984-04
|
$99,908
|
$49,954
|
LIU, WEI
|
MAYO CLINIC ARIZONA
|
|
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation
|
5K01CA181292-03
|
$119,534
|
$29,884
|
CASTILLO, RICHARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
A molecular mechanism whereby metformin protects against liver cancer
|
5R21CA185021-02
|
$156,277
|
$156,277
|
XIAO, HUA
|
MICHIGAN STATE UNIVERSITY
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
1R01CA190776-01
|
$666,229
|
$666,229
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
|
2R44CA165314-02A1
|
$632,643
|
$632,643
|
LU, XUANYONG
|
IMCARE BIOTECH
|
|
A novel mediator of obesity associated hepatocellular carcinoma (HCC)
|
5R21CA183954-02
|
$165,844
|
$165,844
|
SARKAR, DEVANAND
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
A scalable platform for target validation in GEMM models of gastrointestinal mali
|
1R01CA195787-01
|
$674,831
|
$337,416
|
LOWE, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 - 03152
|
$1,131,149
|
$56,557
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrantly secreted glycoproteins as markers of liver cancer
|
5U01CA168856-04
|
$336,596
|
$336,596
|
MEHTA, ANAND
|
DREXEL UNIVERSITY
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S1
|
$62,498
|
$625
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-39S2
|
$125,000
|
$1,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$77,044
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Active Viral Hepatitis Diagnostics to Support Prevention/Treatment of HCC
|
5UH2CA189965-02
|
$445,007
|
$445,007
|
MURPHY, ROBERT
|
NORTHWESTERN UNIVERSITY
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-03
|
$638,721
|
$127,744
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
|
5R01CA161694-04
|
$292,725
|
$292,725
|
SELL, STEWART
|
WADSWORTH CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$1,709
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$40,518
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$498,373
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance of Glycobiologists for Detection of Cancer
|
5U01CA168926-04
|
$366,151
|
$366,151
|
GOLDMAN, RADOSLAV
|
GEORGETOWN UNIVERSITY
|
|
Altered Growth Factor Pathways in Biliary Cancer
|
5R01CA083650-13
|
$307,269
|
$307,269
|
SIRICA, ALPHONSE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention
|
5R01CA164335-04
|
$303,379
|
$303,379
|
STAVELEY-O'CARROLL, KEVIN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Analysis of Racial Disparities in HCC by Systems Metabolomics
|
1U01CA185188-01A1
|
$269,790
|
$269,790
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S5
|
$1,917,600
|
$19,176
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S6
|
$50,000
|
$500
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S7
|
$124,932
|
$1,249
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
Asian Community Cancer Health Disparities Center (ACCHDC)
|
3U54CA153513-05S3
|
$351,725
|
$56,276
|
MA, GRACE
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$87,199
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma
|
1R21CA191814-01A1
|
$221,653
|
$221,653
|
MERCER, CAROL
|
UNIVERSITY OF CINCINNATI
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,530,484
|
$726,524
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$126,207
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$4,486
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$7,322
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beneficial effects of Honokiol against liver cancer
|
1R21CA185943-01A1
|
$215,284
|
$215,284
|
SAXENA, NEERAJ
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$76,885
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma
|
5R01CA155297-05
|
$505,725
|
$505,725
|
BRINDLEY, PAUL
|
GEORGE WASHINGTON UNIVERSITY
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-02
|
$280,000
|
$5,600
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
c-Myc-regulated microRNAs in normal and pathologic cellular physiology
|
5R01CA120185-09
|
$293,037
|
$146,519
|
MENDELL, JOSHUA
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
|
2R01CA118374-07A1
|
$342,000
|
$171,000
|
RYEOM, SANDRA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$6,695
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer cell signaling through lipids complexed to proteins
|
7K01CA172957-04
|
$112,202
|
$37,027
|
BLIND, RAYMOND
|
VANDERBILT UNIVERSITY
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S1
|
$62,499
|
$625
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S2
|
$47,351
|
$474
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S4
|
$31,250
|
$313
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-39S5
|
$59,750
|
$598
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
5P30CA016086-39
|
$6,790,080
|
$67,901
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support (Core) Grant
|
2P30CA014051-44
|
$3,572,644
|
$71,453
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S1
|
$120,000
|
$2,400
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S2
|
$123,768
|
$2,475
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Liver Cancer for this search: $70,286,751
|